Management of carpal tunnel syndrome.
Estimates suggest that around 1 in 10 people develop carpal tunnel syndrome at some point. The condition comprises potentially disabling sensory and/or motor symptoms in the hand, caused by compression of the median nerve, and carries considerable implications for employment and healthcare costs. Current standard treatment options are splinting, local corticosteroid injections and surgery, and there are a range of other suggested treatments. Here we review how best to manage patients with carpal tunnel syndrome.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D002349:Carpal Tunnel Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D015552:Injections, Intralesional; D009431:Neural Conduction / Q000502:physiology; D010808:Physical Examination / Q000379:methods; D012017:Referral and Consultation; D012307:Risk Factors; D013165:Splints; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones